Cancer news
Cancers' sweet tooth may be weakness
Nov 18, 2009 |
5 / 5 (4) |
0
The pedal-to-the-metal signals driving the growth of several types of cancer cells lead to a common switch governing the use of glucose, researchers at Winship Cancer Institute of Emory University have discovered.
Common pain relief medication may encourage cancer growth
Nov 18, 2009 |
5 / 5 (3) |
0
Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of ...
Reflux esophagitis due to immune reaction, not acute acid burn
Nov 19, 2009 |
5 / 5 (3) |
0
Contrary to current thinking, a condition called gastroesophageal reflux disease (GERD) might not develop as a direct result of acidic digestive juices burning the esophagus, UT Southwestern Medical Center ...
Bladder cancer risks increase over time for smokers
Nov 16, 2009 |
5 / 5 (1) |
1
Risk of bladder cancer for smokers has increased since the mid-1990s, with a risk progressively increasing to a level five times higher among current smokers in New Hampshire than that among nonsmokers in 2001-2004, according ...
World's first delivery of intra-arterial Avastin directly into brain tumor
Nov 17, 2009 |
5 / 5 (1) |
0
Neurosurgeons from NewYork-Presbyterian Hospital/Weill Cornell Medical Center performed the world's first intra-arterial cerebral infusion of Avastin (bevacizumab) directly into a patient's malignant brain tumor. This novel ...
Researchers identify role of gene in tumor development, growth and progression
Nov 20, 2009 |
5 / 5 (1) |
0
Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth ...
Wistar researchers show targeting 'normal' cells in tumors slows growth
Nov 16, 2009 |
1 / 5 (1) |
0
Targeting the normal cells that surround cancer cells within and around a tumor is a strategy that could greatly increase the effectiveness of traditional anti-cancer treatments, say researchers at The Wistar Institute.
New combination therapy could deliver powerful punch to breast cancer
Nov 16, 2009 |
not rated yet |
0
A powerful new breast cancer treatment could result from packaging one of the newer drugs that inhibits cancer's hallmark wild growth with another that blocks a primordial survival technique in which the cancer ...
New mammogram advice raises questions, concerns
Nov 16, 2009 |
not rated yet |
0
(AP) -- For many women, getting a mammogram is already one of life's more stressful experiences. Now, women in their 40s have the added anxiety of trying to figure out if they should even be getting one at ...
Imaging techniques may help predict response to head and neck cancer treatment
Nov 16, 2009 |
not rated yet |
0
A combination of imaging tests conducted six to eight weeks after patients complete chemoradiotherapy for head and neck cancer may help identify patients who will respond to treatment and those who will require surgical follow-up, ...
For many, mammography every other year has benefits of annual screening, but less harm
Nov 17, 2009 |
not rated yet |
1
A comprehensive analysis of various mammography screening schedules suggests that biennial (every two years) screening of average risk women between the ages of 50 and 74 achieves most of the benefits of annual screening, ...
African-American men at higher risk of false positives in prostate testing
Nov 17, 2009 |
not rated yet |
0
(PhysOrg.com) -- While an elevated prostate-specific antigen (PSA) test can be frightening news for men, new research shows that sometimes the levels are caused by a naturally occurring hormone, and may not indicate a need ...
Solving the 50-year-old puzzle of thalidomide
Nov 17, 2009 |
not rated yet |
1
Research into the controversial drug thalidomide reveals that the mechanism through which the drug causes limb defects is the same process which causes it to damage internal organs and other tissues. The article, published ...
Cancer patients and doctors report drug side effects differently
Nov 17, 2009 |
not rated yet |
0
In clinical trials for cancer, it is standard for clinicians rather than patients to report adverse symptom side effects from treatments, such as nausea and fatigue. At present, patient self-reporting, although important, ...
Kill the cancer, not the patient: New toxicity testing approach could make chemo drugs safer
Nov 18, 2009 |
not rated yet |
0
For cancer patients on chemotherapy, the "cure" can be as deadly as the disease itself. Adverse drug reactions are one of the leading causes of death among patients receiving cancer treatment.
